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Abstract
Aim: In recent years several studies have shown increasing rate of upper gastric cancers regarding
to decrease in distal gastric cancers. The aim of this study was to describe the trend of gastric
cancers by location in Iran, which is one of the countries with high prevalence of gastric cancers.
Methods: All registered cases of gasterectomy in Tehran Cancer Institute from 1969 through
2004 were re-evaluated clinicopathologically. The stomach was anatomically divided into the upper,
middle, and lower third. The prevalence of gastric cancers in 5 year periods estimated by location
and the changes trough the time was evaluated independently and in aspect of age and sex.
Results: Over 36 years, the prevalence of cancers in the upper and middle third of the stomach
have increased and that of the lower third has decreased. These changes were seen in both sexes
and age groups under and over 50 and it was more significant in younger.
Conclusion: The results are the same as most previous reports in other countries. This can
indicate different risk factors as well as confrontation with them. However in regard to few
numbers of cases in this study, a population-based study is recommended for confirmation.
Introduction
Gastric cancer incidence has markedly decreased in some
countries, such as United State [1] but it remains high in
others such as Japan [2] and Iran [3,4]. It is the first lead-
ing cause of cancer-related deaths in men, and the second
one among women in Iran [3]. According to the identifi-
cation of many predisposing factors in recent years, inci-
dence of gastric cancer has declined in most countries,
especially in developed countries [2,5]. Meanwhile, many
studies show that adenocarcinomas arising from gastric
cardia have increased, especially in areas with low inci-
dence of gastric cancer [6-22]. By contrast, some of the
studies have not shown any increase in cardia carcinoma
incidence [23,24]. Two important population-based stud-
ies indicate that the cardia carcinoma incidence in differ-
ent countries has been inconsistent [25,26]. There is also
a belief that this rising incidence has been confined to the
areas with low-risk for gastric carcinoma [23,24],
although there are some contradictory studies [19,20,27].
It should be remembered that in spite of a large number
of studies carried out in low-risk countries [2], very rare
ones have been performed in high-risk countries.
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Although Iran is one of the countries with high incidence
of gastric cancers, there is no information about possible
gastric carcinoma location change in Iranian patients.
Therefore, this study intends to evaluate the gastric carci-
noma location trend during the last 36 years.
Materials and methods
As a preliminary step, all cases of gastrectomy specimens
due to carcinoma during 1969–2004 in Cancer Institute
of Tehran Medical University, the oldest main referral
center for cancerous patients in Iran, were collected. All
new cases with diagnosis of adenocarcinoma were also
included in the course of this study. All the related pathol-
ogy reports and hematoxylin and eosin sections were re-
evaluated and reviewed by two pathologists. In cases with
inappropriate slides new sections were cut and stained.
Cases with damaged paraffin blocks were excluded from
the study.
Anatomic site of each tumor was first determined by refer-
ring to the relevant macroscopic description of pathology
report and then correlated with the latest guidelines for
gastric cancer classification by Japanese Research Society
for Gastric Cancer, in which the stomach is anatomically
delineated into the upper, middle and lower thirds by
dividing the lesser and greater curvature in two equidis-
tant points and joining these points [28]. Tumors located
predominantly in the gastro-esophageal junction and car-
dia were determined to be in the upper third of the stom-
ach, those located in the pylorus were considered to be in
the lower third and those located in the mid-body were
determined to be in the middle third of the stomach. If
tumor was located across adjacent regions, the region con-
taining the greater proportion of the tumor was consid-
ered to be the tumor's main location. Cardia was defined
as region between 1 cm proximal and 2 cm distal to gas-
tro-esophageal junction [29]. In regard of rather low
number of cases per year, each five years categorized in
one group and then the trend of location during this 35
years was evaluated.
Clinical data, including sex and age, were gathered from
pathologic reports. Demographic and clinical data were
analyzed via Pearson's X2, ANOVA, and Somer's d. A value
of P < 0.05 was considered to be statistically significant.
Invasion of gastric adenocarcinoma by tumor location Figure 1
Invasion of gastric adenocarcinoma by tumor location. The serosal invasion was higher in adenocarcinoma of upper and middle 
third (P = 0.000)
0
10
20
30
40
50
60
70
Upper Middle Lower
Locatin
P
r
o
p
r
t
i
o
n
 
(
%
)
serosa
muscular
mucosa   &
submucosaDiagnostic Pathology 2006, 1:5 http://www.diagnosticpathology.org/content/1/1/5
Page 3 of 7
(page number not for citation purposes)
Results
All 1310 cases of gastrectomy for adenocarcinoma during
1969 to 2004 in Tehran Cancer Institute were collected,
from which 78.5%were male. The mean age was 56.6 ±
21.2. In gastric sublocation analysis, 89 cases were
excluded because of unavailability of clinical data and 12
cases for multicentricity. Among the rest, 298 (22.7%)
were in the upper third, 325 (24.8%) in the middle third
and 586 (44.7%) in the lower third. According to lauren
classification 54.9% were intestinal type and the remain-
ing was diffuse type.
There was no sexual difference between locations (Pear-
son chi-square, X2 = 1.47, P = 0.479). Analysis of variance
showed a significant difference in age at diagnosis
between adenocarcinomas appeared in three part of stom-
ach (P < 0.001) and in two genders (P < 0.006), but no sig-
nificant correlation between location of tumors and
gender (P > 0.05).
There was significant difference between locations and the
degree of invasion (Pearson chi-square, X2 = 26.5, P  =
0.000) which means serosal invasion was higher in aden-
ocarcinoma of upper and middle third (Figure 1).
Prevalence of adenocarcinoma of upper and middle third
has increased in recent 36 years. By contrast, that of lower
third has decreased (Somer's d = -0.252; P <0.001)(Figure
2). The trend of location was seen in both sexes; and it was
approximately equal (Somer's d: -0.250 in males and -
0.263 in female; both P < 0.001)(figure 3). This increasing
trend did not vary by age (under 50 versus upper 50) but
was more pronounced among the younger (Somer's d: -
0.239 in youngers and -0.227 in elders; both P < 0.001)
(figure 4).
Discussion
Adenocarcinoma of the upper and middle third of stom-
ach shows an increasing trend during the last 30 years in
Iran. Gastric cancers are the most common malignant
neoplasm among Iranians [3,4]. They are the first leading
causes of cancer-related deaths in Iranian males and the
second in Iranian females [3] and, despite progress in
diagnosis and treatment they have still poor prognosis
(five year survival less than 20%)[1]. This study is the first
one that focusing on changing of location of gastric aden-
ocarcinoma in Iran. This study had some limitations; the
most important one is that our study was not a popula-
tion-based study, because cancer registry system in Iran is
not complete yet and designing a population-based study
is impossible now. However we believe that our study has
minimal selection bias because 1) The selected center for
Trend in location of gastric adenocarcinoma in each sex Figure 3
Trend in location of gastric adenocarcinoma in each sex. The increasing prevalence of adenocarcinomas of upper and middle 
parts of stomach is seen in booth sexes (Somer's d: -0.250 in males and -0.263 in female; both P < 0.001)
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Trend in location of gastric adenocarcinoma Figure 2
Trend in location of gastric adenocarcinoma. The diagram 
shows increasing prevalence of adenocarcinomas of upper 
and middle parts of stomach during recent 35 years (Somer's 
d = -0.252;P < 0.001).
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this study is the most important referral center in Iran, 2)
The cases were collected for a period of 36 years from all
over the country. The other limitation was the incomplete
macroscopic description of reports, particularly among
early cases, a fact which leads to uncertainty in defining
location sub-classification of tumors.
The advantage of this study is that all the related pathol-
ogy reports and hematoxylin and eosin sections were
reviewed by two pathologists. Consequently the error of
misclassification that is propounded for increasing inci-
dence of cardia adenocarcinoma in some studies [6,31]
was minimized.
Our study showed significant change in distribution of
gastric adenocarcinoma as prevalence of carcinoma of
upper and lower third reached from 15% in the first 10
years to 36% in the last 10 years of study period. One of
the reasons that has usually been brought up for the
increasing incidence of upper third gastric carcinoma is
the decreasing incidence of lower third carcinoma due to
of H. pylori eradication treatments leading to the relative
increase of upper third carcinoma [32-37]. But this study
showed not only decrease of prevalence of lower third
adenocarcinomas but also independently increase of
prevalence of upper and middle third adenocarcinoma
(Spearman's rho: upper: 0.750 (p ~ 0.05); middle: 0.750
(p ~ 0.05); lower: -0.964 (P < 0.01))(Figure 5). Misclassi-
fication is another reason that has been brought up in
some studies [7,31], but as will be shown later, this was
limited in this study.
Disclosing of separate risk factors for cancers of upper
third of stomach made this increasing incidence explana-
tion available. Although many evidences show that treat-
ment of H. pylori infection, especially cagA+ strains can
decrease incidence of distal gastric adenocarcinomas, sev-
eral recent studies have noted that this treating might
increase the risk of peptic esophagitis and adenocarci-
noma of esophagus and cardia [32,37-39]. However some
studies show that adenocarcinomas of distal esophagus
are inversely associated with H. pylori but gastric cardia
cancers have an unclear association with it [21,40-45].
Other risk factors that former studies have propounded
are amount of dietary antioxidant [33], fruit and vegetable
consumption [46], cigarette smoking [47,54] and obesity
Total number of gastric adenocarcinoma per year was signifi- cantly decreased in recent 35 years and it was due to  decreasing prevalence of lower third gastric adenocarcinoma Figure 5
Total number of gastric adenocarcinoma per year was signifi-
cantly decreased in recent 35 years and it was due to 
decreasing prevalence of lower third gastric adenocarcinoma. 
Spearman's rho: upper: 0.750 (p ~ 0.05); middle: 0.750 (p ~ 
0.05); lower: -0.964 (P < 0.01)
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Trend in location of gastric adenocarcinoma by age. The increasing prevalence of adenocarcinomas of upper and middle parts 
of stomach is seen in booth groups and it is a little more pronounced in younger patients (Somer's d: -0.239 in younger and -
0.227 in elders; both P < 0.001)
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[53,55,56]. However in some reports gastric cardia cancers
are only modestly associated with obesity [42] and are
known to have no association with antioxidant intake
[41]. In addition to the above risk factors Epstein – Barr
virus (EBV) has been recently found to be associated with
cardia tumors and it increases the risk of gastric cardia
tumors five times [57]. Genetic factors are also important
[58,59] and it has been shown that familial gastric cancers
are frequently located in the cardia and are usually more
aggressive than sporadic gastric cancers [60,61].
Urban development and industrialized living in recent
decades in Iran have increased the probability of confron-
tation with much of the above risk factors, and this can be
the cause of increasing prevalence of adenocarcinomas of
upper third of stomach in this study. Decreasing preva-
lence of carcinoma of lower third of stomach can be due
to early treatment of H. pylori infection in recent years
and elimination of noxious diet. Cancers of middle third
and lower third of stomach have the same risk factors;
therefore we may normally expect a decreasing incidence
of them. However our findings show an increasing preva-
lence of middle third gastric adenocarcinoma; the same
was seen in another study in Japan [27]. We have no
explanation for this and it needs more confirmatory stud-
ies.
In this study the trend of location was seen in both sexes,
and it was approximately equal in both sexes. But
Devesa's study in united state [6] and Botterweek's study
in Slovakia, England, Wales and Scotland show the trends
was more pronounced in females[25]. In other studies it
was seen exclusively in males [12,16,27,62]. Less confron-
tation with risk factors such as smoking and other genetic
and hormonal differences are propounded for explana-
tion; however regarding of contradictory results this gen-
der difference is largely unexplained and we could not
find it [26].
With regard to small number of cases in our study an accu-
rate evaluation of age effect in distribution of gastric can-
cers was impossible. However in a general analysis
increasing prevalence of carcinomas of upper and middle
third was a little more pronounced among the younger.
This finding is against with other studies [6,27].
Generally increasing prevalence of upper third adenocar-
cinomas in this study is similar to increasing incidence
seen in the United States [6,21,63,64], England [10,11],
Denmark [12], the Netherlands [13], Sweden [14], New
Zealand [15], Norway [16], Slovakia [17], Austria [18]
and France [65]. It was not seen in all areas of the world.
In two important population-based studies – Corley's
[26] and Botterweek's [25] study – the results were not
consistent in different areas and this can be due to differ-
ent risk factors. There are also some contradictory results
in the same areas. For example in Japan in one 30 year
period study no change in gastric cancer location was seen
[24], but in two other studies increasing incidences of gas-
tric cardia cancer were seen [19,20].
Several studies have suggested that increasing incidence of
proximal gastric cancers is seen in areas with low-risk for
gastric cancer [23,24], but our findings in Iran which is
one of the regions with high frequency did not show this
change, similar to some other studies in Japan[19,20,27].
In conclusion, our findings show an increasing prevalence
of proximal gastric cancers in our center during the last
four decades. These findings express the changing in life
style and so the risk factors; however we should consider
other factors such as misclassification, and probability of
selection bias in this study in regard of a few numbers of
cases. Therefore we recommend a confirmatory popula-
tion-based study. There are also hypothesis about histo-
logical trends in gastric adenocarcinoma, so in regard of
lacking such a study in Iran our next step will be analysis
of histological trend in gastric adenocarcinoma.
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